The role of nintedanib and pirfenidone in the treatment of idiopathic pulmonary fibrosis and review of recent clinical trials of IPF therapy
Idiopathic pulmonary fibrosis (IPF) is a chronic, rare disease characterized by continuous fibrosis of the lung parenchyma.It mainly affects the elderly; however, it is increasingly being diagnosed in younger patients as well.Risk factors include smoking, occupational dust exposure and genetic factors.Symptoms of IPF include shortness of breath, dr